TANDAB-131

Recombinant Anti-CD8 x Anti-PSCA Bispecific Antibody (TandAb)

A bispecific antibody that is expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.

Ask for quotation

BSDB-167

Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (Diabody)

A bispecific antibody that is expressed as two polypeptide chains respectively. The two chains are cross-over pairing to form a dimer. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.

Ask for quotation

DART-064

Recombinant Anti-B7H6 x Anti-CD3 Bispecific Antibody (DART)

A bispecific antibody that is expressed as two polypeptide chains respectively, and a disulfide bond is introduced into the chains. This BsAb can retarget T cells to tumor cells. It is designed for the research of Hematologic neoplasms; Solid tumors therapy.

Ask for quotation

MBS178255-01mg

Anti-PSCA Antibody

766.34 €

MBS178255-5x01mg

Anti-PSCA Antibody

2594.94 €

STJ11100914

Anti-PSCA antibody

This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. This gene includes a polymorphism that results in an upstream start codon in some individuals; this polymorphism is thought to be associated with a risk for certain gastric and bladder cancers. Alternative splicing results in multiple transcript variants.

655.09 €